Fortress Biotech, Inc.
FBIO
$2.29
$0.073.15%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.82M | 3.99M | -14.73M | -41.16M | -46.00M |
| Total Depreciation and Amortization | 4.66M | 4.63M | 4.43M | 4.46M | 4.46M |
| Total Amortization of Deferred Charges | 1.40M | 1.37M | 1.44M | 1.74M | 2.05M |
| Total Other Non-Cash Items | -53.56M | -56.10M | -50.16M | -22.64M | -32.59M |
| Change in Net Operating Assets | -25.10M | -20.02M | -21.07M | -16.77M | -8.13M |
| Cash from Operations | -65.78M | -66.14M | -80.09M | -74.37M | -80.19M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 1.17M | 1.17M | 1.17M | 1.17M | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 8.96M | 8.96M | 6.09M | -- | -- |
| Other Investing Activities | -- | -15.00M | -15.00M | -15.00M | -15.00M |
| Cash from Investing | 10.12M | -4.88M | -7.75M | -13.84M | -15.00M |
| Total Debt Issued | -- | 5.00M | 38.67M | 43.67M | 43.67M |
| Total Debt Repaid | -700.00K | -1.38M | -1.88M | -1.88M | -1.25M |
| Issuance of Common Stock | 3.96M | 4.22M | 10.47M | 12.17M | 22.23M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -265.00K | -265.00K | -265.00K | -150.00K | -- |
| Total Dividends Paid | -- | 0.00 | 0.00 | -2.01M | -4.02M |
| Other Financing Activities | 74.45M | 89.96M | 38.18M | 43.11M | 10.01M |
| Cash from Financing | 77.44M | 97.54M | 85.18M | 94.92M | 70.64M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 21.79M | 26.52M | -2.66M | 6.72M | -24.55M |